Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 13

List of Figures
Figure No.
Figure Title
Page No.
Figure 21: Regional Expected Healthcare Industry Growth Rate By Year 2020 52
Figure 22: Global COPD Drugs Market Size, By Drug Type, 2017 (%) 54
Figure 23: Global COPD Drugs Market Size, By Drug Type, 2023F (%) 55
Figure 24: Global Combination Therapy COPD Drugs Market, By Value, 2013-2017 (USD Million) 56
Figure 25: Global Combination Therapy COPD Drugs Market, By Value, 2018-2023(USD Million) 56
Figure 26: Global Anticholinergics COPD Drugs Market, By Value, 2013-2017 (USD Million) 57
Figure 27: Global Anticholinergics COPD Drugs Market, 2018-2023(USD Million) 57
Figure 28: Global Beta-Agonist COPD Drugs Market, By Value, 2013-2017 (USD Million) 58
Figure 29: Global Beta-Agonist COPD Drugs Market, By Value, 2018-2023(USD Million) 58
Figure 30: Global ICS COPD Drugs Market, By Value, 2013-2017 (USD Million) 59
Figure 31: Global ICS COPD Drugs Market, By Value, 2018-2023(USD Million) 59
Figure 32: Global Other COPD Drugs Market, By Value, 2013-2017 (USD Million) 60
Figure 33: Global Other COPD Drugs Market, By Value, 2018-2023(USD Million) 60
Figure 34: Global Market Attractiveness, By Product Type, 2023F 61
Figure 35: Global COPD Drugs Market Size, By Region, 2017 (%) 63
Figure 36: Global COPD Drugs Market Size, By Region, 2023F (%) 63
Figure 37: North America COPD Drugs Figure 38: United States Spending on Medicines, 2013-2017 (In USD Billion) 67
Figure 39: Patented and Non-Patented Drugs Sales in Canada, 2013-2016 (USD Billion) 67
Figure 40: North America, Smoking Prevalence, Age 15+, 2013-2016 68
Market, By Value, 2013-2017 (USD Million)
(c) AZOTH Analytics
65
13